AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022-Reference-Cited by-同舟云学术

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Published:2022 Issue:4 Volume:17 Page:403-420
ISSN:1661-3791
Container-title:Breast Care
language:en
Short-container-title:Breast Care

Author:

Ditsch Nina,Wöcke Achim,Untch Michael^ORCID,Jackisch Christian,Albert Ute-Susann,Banys-Paluchowski Maggie,Bauerfeind Ingo,Blohmer Jens-Uwe^ORCID,Budach Wilfried,Dall Peter^ORCID,Fallenberg Eva Maria,Fasching Peter A.,Fehm Tanja N.,Friedrich Michael,Gerber Bernd,Gluz Oleg,Harbeck Nadia^ORCID,Heil Jörg,Huober Jens,Kreipe Hans H.,Krug David^ORCID,Kühn Thorsten,Kümmel Sherko,Kolberg-Liedtke Cornelia,Loibl Sibylle,Lüftner Diana,Lux Michael Patrick,Maass Nicolai,Mundhenke Christoph,Nitz Ulrike,Park-Simon Tjoung-Won^ORCID,Reimer Toralf,Rhiem Kerstin,Rody Achim,Schmidt Marcus^ORCID,Schneeweiss Andreas,Schütz Florian,Sinn Hans-Peter^ORCID,Solbach Christine,Solomayer Erich-Franz^ORCID,Stickeler Elmar,Thomssen Christoph,Witzel Isabell^ORCID,Müller Volkmar,Janni Wolfgang,Thill Marc^ORCID

Abstract

Introduction: The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer as an interdisciplinary team consists of specialists from gynecological oncology, pathology, diagnostic radiology, medical oncology, and radiation oncology with a special focus on breast cancer. Methods: The updated evidence-based treatment recommendation 2022 for early breast cancer (EBC) and metastatic breast cancer of the AGO Task Force has been released. Results and Conclusion: This paper captures the update of EBC.

Publisher

S. Karger AG

Subject

Oncology,Surgery

Reference25 articles.

1. Parity and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis

2. Performance of Digital Breast Tomosynthesis, Synthetic Mammography, and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis

3. Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial

4. Preoperative breast cancer staging with multi-modality imaging and surgical outcomes

5. Polymorphous adenocarcinoma of the breast—an exceptionally rare entity: Clinicopathological description of a case and brief review

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO;European Journal of Surgical Oncology;2024-01

2. Current bi‐national attitudes towards targeted axillary dissection;ANZ Journal of Surgery;2023-12-27

3. Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling;Oncology Reports;2023-11-15

4. Assessment of Selenium and Mercury Levels in Breast Tissue of Malignant and Healthy Female Patients in Pakistan: Implications for Breast Cancer Screening and Treatment;2023-11-07

5. Use of the Gene Expression Test Prosigna® in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67;Breast Care;2023-10-17